Pharmaceutical

AstraZeneca picks first Treg cell therapy from Quell Therapeutics partnership

AstraZeneca will advance preclinical and clinical development of the Type 1 Diabetes cell therapy candidate.

Nov 19, 2024 - 06:00
AstraZeneca picks first Treg cell therapy from Quell Therapeutics partnership
AstraZeneca will advance preclinical and clinical development of the Type 1 Diabetes cell therapy candidate.
Read the original article

Tags:

Previous Article

CHMP recommends AstraZeneca’s Tagrisso for EU approval for NSCLC

Next Article

Intellia’s gene editing therapy shows early potential in rare heart condition

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

J&J signs Stelara biosimilar settlement deal with Formycon and Fresenius

J&J signs Stelara biosimilar settlement deal with Formy...

Aug 8, 2023

EMA’s CHMP to approve BMS’ Opdivo for colorectal cancer

EMA’s CHMP to approve BMS’ Opdivo for colorectal cancer

Nov 19, 2024

Is the flu shot market a slam dunk for mRNA vaccines? Experts aren’t so sure

Is the flu shot market a slam dunk for mRNA vaccines? E...

Dec 5, 2023